Archived Newsletters

41. 06.11.19 -- Answering Today's Pharma Dilemma Of Build Or Buy
    6/11/2019
    06/11/19 Outsourced Pharma Newsletter
42. 06.07.19 -- Do You Have The Right Tools To Determine CQA?
    6/7/2019
    06/07/19 Outsourced Pharma Newsletter
43. 06.06.19 -- Updates From Thermo Fisher Scientific - Acquisitions And Capabilities
    6/6/2019
    06/06/19 Outsourced Pharma Newsletter
44. 06.05.19 -- Novartis And The Price Of A Child's Life
    6/5/2019
    06/05/19 Outsourced Pharma Newsletter
45. 05.31.19 -- The Challenges Of Biopharmaceutical Quality
    5/31/2019
    05/31/19 Outsourced Pharma Newsletter
46. 05.29.19 -- The Remarkable Rise Of Japan's CDMOs
    5/29/2019
    05/29/19 Outsourced Pharma Newsletter
47. 05.28.19 -- Optimizing API Development And Manufacturing
    5/28/2019
    05/28/19 Outsourced Pharma Newsletter
48. 05.23.19 -- Strategies For The Future Of Biopharma
    5/23/2019
    05/23/19 Outsourced Pharma Newsletter
49. 05.22.19 -- Arena Pharmaceuticals Straightens Out The "Tech Ops" Circle
    5/22/2019
    05/22/19 Outsourced Pharma Newsletter
50. 05.15.19 -- Don't Put "Descartes Before The Horse" When Outsourcing
    5/15/2019
    05/15/19 Outsourced Pharma Newsletter